About Genewiz
Genewiz is a company based in South Plainfield (United States) founded in 1999 by Amy Liao and Steve Sun was acquired by Brooks Automation in September 2018.. The company has 452 employees as of December 31, 2022. Genewiz has completed 1 acquisition, including Beckman Coulter Genomics. Genewiz offers products and services including Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis. Genewiz operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
- Headquarter South Plainfield, United States
- Employees 452 as on 31 Dec, 2022
- Founders Amy Liao, Steve Sun
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$143.28 K (USD), Grant
Jun 01, 2020
-
Investors
Brooks Automation
& 4 more
-
Employee Count
452
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Brooks Automation
(Sep 26, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genewiz
Genewiz offers a comprehensive portfolio of products and services, including Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-throughput DNA sequencing for research applications
Accurate DNA sequencing for mutation analysis
Custom DNA and RNA synthesis for experiments
Standard and targeted plasmid DNA prep services
Custom DNA and RNA oligos for sequencing
Unlock access to complete
Unlock access to complete
Software Development Team
50 people
Sales and Marketing
39 people
Leadership Team
24 people
Senior Team
19 people
Account Team
17 people
Finance and Accounting
16 people
Legal and Compliance
9 people
Human Resources and Administration
9 people
Unlock access to complete
Funding Insights of Genewiz
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $143,283
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Grant - Genewiz | Valuation |
investors |
|
| Jan, 2016 | Amount | Private Equity Round - Genewiz | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genewiz
Genewiz has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Brooks Automation, Orbimed and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genewiz
Genewiz has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Beckman Coulter Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Next-generation and Sanger sequencing services are provided.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Genewiz
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genewiz Comparisons
Competitors of Genewiz
Genewiz operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing and genomics services are provided globally.
|
|
| domain | founded_year | HQ Location |
Genome sequencing, analysis, and genetic screening services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genewiz
Frequently Asked Questions about Genewiz
When was Genewiz founded?
Genewiz was founded in 1999 and raised its 1st funding round 17 years after it was founded.
Where is Genewiz located?
Genewiz is headquartered in South Plainfield, United States. It is registered at South Plainfield, New Jersey, United States.
Who is the current CEO of Genewiz?
Amy Liao is the current CEO of Genewiz. They have also founded this company.
How many employees does Genewiz have?
As of Dec 31, 2022, the latest employee count at Genewiz is 452.
What does Genewiz do?
Genewiz was founded in 1999 and is headquartered in South Plainfield, United States. Operations focus on the life sciences sector, where a variety of genomic services are delivered, including DNA sequencing, gene synthesis, plasmid preparation, site-directed mutagenesis, fragment analysis, SNP discovery sequencing, next-generation sequencing, bioinformatics, and GLPcGMP regulatory support. Molecular biology services are also offered to support research and development needs.
Who are the top competitors of Genewiz?
Genewiz's top competitors include Novogene Corporation, Source BioScience and Macrogen.
What products or services does Genewiz offer?
Genewiz offers Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis.
How many acquisitions has Genewiz made?
Genewiz has made 1 acquisition, including Beckman Coulter Genomics.
Who are Genewiz's investors?
Genewiz has 5 investors. Key investors include Brooks Automation, Orbimed, European Union, Ampersand Capital Partners, and PrimeValue Capital Management.